false
Catalog
Multiprofessional Critical Care Review: Adult 2024 ...
Question and Answer Session 2
Question and Answer Session 2
Back to course
Pdf Summary
In this scenario, the patient is presenting with signs and symptoms consistent with ethylene glycol toxicity. Laboratory findings of metabolic acidosis, elevated liver enzymes, and oxalate crystalluria support this diagnosis. The most appropriate treatment for ethylene glycol toxicity is fomepizole, a potent inhibitor of alcohol dehydrogenase. N-acetylcysteine, activated charcoal, and methylene blue are not indicated for the treatment of ethylene glycol toxicity.
Keywords
ethylene glycol toxicity
signs and symptoms
metabolic acidosis
elevated liver enzymes
oxalate crystalluria
fomepizole
alcohol dehydrogenase inhibitor
N-acetylcysteine
activated charcoal
methylene blue
Society of Critical Care Medicine
500 Midway Drive
Mount Prospect,
IL 60056 USA
Phone: +1 847 827-6888
Fax: +1 847 439-7226
Email:
support@sccm.org
Contact Us
About SCCM
Newsroom
Advertising & Sponsorship
DONATE
MySCCM
LearnICU
Patients & Families
Surviving Sepsis Campaign
Critical Care Societies Collaborative
GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. |
Privacy Statement
|
Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.
×
Please select your language
1
English